Stem cell treatment for active ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 40 years old.
- You need to have active symptoms of ankylosing spondylitis, like significant back pain and stiffness, plus elevated blood markers of inflammation.
- You must not have used biologic medications (like Humira or Enbrel) in the last 6 months.
- You cannot have certain other serious health conditions, like kidney disease, uncontrolled heart problems, or active infections.
- You must be willing to stop certain other arthritis medications (except methotrexate or sulfasalazine) at least 4 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue is safe and well-tolerated in people with active ankylosing spondylitis (AS). It may reduce inflammation and help control symptoms when standard treatments are not working well enough.
This study tests a new treatment using umbilical cord stem cells given by injection to help reduce inflammation and improve symptoms of ankylosing spondylitis. It is for people who have not gotten enough relief from standard medications, including biologics.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.